Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael Hyatt currently holds 368,188 shares of ENDO PHARMACEUTICALS HOLDINGS INC (ENDP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Hyatt has been a net seller of ENDP stock. They have purchased $0 and sold $6.6M worth of shares.
Michael Hyatt's most recent insider trade was on Jun 11, 2021, when they sold 47,924 shares at $0.00 per share.
Michael Hyatt serves as Executive at ENDO PHARMACEUTICALS HOLDINGS INC (ENDP). They have executed 52 insider transactions totaling $6.6M over their tenure at the company.
Michael Hyatt holds the position of Executive at ENDO PHARMACEUTICALS HOLDINGS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Michael Hyatt has shown a selling trading pattern, with $0 in total purchases and $6.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Michael Hyatt was on Dec 15, 2012, when they sold $2.0M worth of SHF shares. This transaction involved 47,106 shares at $42.00 per share.
Michael Hyatt currently owns 368,188 shares of ENDO PHARMACEUTICALS HOLDINGS INC (ENDP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael Hyatt's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael Hyatt has 52 Form 4 filings on record as an insider at ENDO PHARMACEUTICALS HOLDINGS INC.
Set alerts for Michael Hyatt and 40,000+ other insiders.